0001193805-19-000400.txt : 20190422 0001193805-19-000400.hdr.sgml : 20190422 20190422183549 ACCESSION NUMBER: 0001193805-19-000400 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190412 FILED AS OF DATE: 20190422 DATE AS OF CHANGE: 20190422 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Neermann Joerg CENTRAL INDEX KEY: 0001773900 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36201 FILM NUMBER: 19760331 MAIL ADDRESS: STREET 1: IMMUNIC AG STREET 2: AM KLOPFERSPITZ 19 CITY: MARTINSRIED STATE: 2M ZIP: 82152 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNIC, INC. CENTRAL INDEX KEY: 0001280776 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562358443 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: AM KLOPFERSPITZ 19 CITY: MARTINSRIED STATE: 2M ZIP: 82152 BUSINESS PHONE: 49 89 250079460 MAIL ADDRESS: STREET 1: AM KLOPFERSPITZ 19 CITY: MARTINSRIED STATE: 2M ZIP: 82152 FORMER COMPANY: FORMER CONFORMED NAME: VITAL THERAPIES INC DATE OF NAME CHANGE: 20040219 3 1 e618388_3-jorg.xml X0206 3 2019-04-12 1 0001280776 IMMUNIC, INC. IMUX 0001773900 Neermann Joerg AM KLOPFERSPITZ 19 MARTINSRIED MUNICH 82152 1 0 0 0 On April 12, 2019, pursuant to an Exchange Agreement, dated as of January 6, 2019, between the Issuer (then known as Vital Therapies, Inc.), Immunic AG ("Immunic"), and the shareholders of Immunic party thereto (the "Exchange Agreement"), the holders of Immunic ordinary shares exchanged all of their outstanding shares for shares of Issuer common stock, resulting in Immunic becoming a wholly-owned subsidiary of the Issuer (the "Transaction"). Immediately following the Transaction, the Issuer changed its name to "Immunic, Inc." In connection with the Transaction, the Reporting Person was appointed Director of the Issuer. /s/ Joerg Neerman 2019-04-22